NGX-4010 for the Treatment of Postherpetic Neuralgia
Herpes Zoster, Neuralgia, Pain
About this trial
This is an interventional treatment trial for Herpes Zoster focused on measuring Dermal assessment, Pain measurement, Diary, Shingles, Neuropathy, Analgesics/*therapeutic use, Capsaicin/*administration & dosage/adverse effects, Herpes Zoster/*complications/drug therapy, Neuralgia/*drug therapy/etiology, Pain, Peripheral Nervous System Diseases/*complications
Eligibility Criteria
Key Eligibility Criteria: Must be diagnosed with PHN and be at least 6 months after crusting of the skin vesicles, with moderate to severe pain. Must not have significant pain due to causes other than PHN (for example, arthritis). Painful areas should not be located on the face, above the hairline of the scalp, and/or in proximity to mucous membranes. Must have intact and unbroken skin at the treatment area. Must be prepared to remain on the same pain medications at the same doses as before the study for the entire duration of the study (1-year). Must not have any implanted medical device (spinal cord stimulator, intrathecal pump or peripheral nerve stimulator) for the treatment of pain. Must not use topical pain medications for PHN. Must be able to comply with study requirements such as completing a daily pain diary, attending study visits and refraining from extensive travel during study participation. No significant medical problems of the heart, kidneys, liver or lungs, or cancer. No history or current problem with substance abuse.
Sites / Locations
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site
- NeurogesX Investigational Site